comprehensive -WSS

comprehensive

author：comprehensive 2025-09-06 01:57:34 - browse：391

Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT — Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： WuXi Biologics execs register to lobby as Congress comes for the company

WSS

The Biogen Aduhelm mess could happen again

Obesity drug from Roche shows promise in early study

The United States must get value

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

What’s missing from the debate over nursing home staff minimums

hotspot

comprehensive

focus

New air purifier tech could be key to improving indoor air quality

AstraZeneca stays mum on Medicare drug pricing negotiations

Psychedelics group wrestles with new pharma identity

340B reform proposal comes out of Senate working group

The cancer drug shortage isn’t new — and neither are the solutions

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

BioMarin wins approval for gene therapy to treat hemophilia A

The United States must get value

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Updated Covid vaccine has 54% effectiveness, new study suggests

hotspot

Abbott's new stent may help patients with peripheral artery disease

What’s missing from the debate over nursing home staff minimums

Gene therapy for Afghan refugees’ infant will be fully covered

Surgery pushed Ben Carson to fame

The United States must get value

Supreme Court to hear if Covid misinformation is protected speech

hotspot

focus

explore

Wikipedia